These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11171510)

  • 1. [Scintigraphy with somatostatin receptors in metastatic insulinoma].
    Delgado M; Razola P; Abós MD; García F; Prats E; Banzo J
    Rev Esp Med Nucl; 2000 Dec; 19(7):505-6. PubMed ID: 11171510
    [No Abstract]   [Full Text] [Related]  

  • 2. An endocrine active insulinoma with extended lymphogenic dissemination.
    Bökenkamp R; Duchateau CS; Stokkel MP
    Clin Nucl Med; 2003 Apr; 28(4):316-7. PubMed ID: 12642713
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatobiliary and Pancreatic: Tumor to tumor metastasis from a primary insulinoma to a hepatic adenoma.
    Xu X; Cong L; Zhao Y
    J Gastroenterol Hepatol; 2019 Mar; 34(3):489. PubMed ID: 30191606
    [No Abstract]   [Full Text] [Related]  

  • 4. Images of interest. Hepatobiliary and pancreatic: Insulinoma metastases with focal hepatic steatosis.
    Sumiyoshi S; Kobayashi Y; Souda K; Takehara Y; Nakamura H
    J Gastroenterol Hepatol; 2005 Apr; 20(4):650. PubMed ID: 15836720
    [No Abstract]   [Full Text] [Related]  

  • 5. [Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].
    Joseph K; Stapp J; Reinecke J; Höffken H; Benning R; Neuhaus C; Trautmann ME; Schwerk WB; Arnold R
    Dtsch Med Wochenschr; 1992 Jun; 117(26):1025-8. PubMed ID: 1352234
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant Pancreatic Insulinoma with Large Hepatic Metastasis.
    Gojwari TA; Ilyas M; Dar MA; Malik AH; Kazimi MJA
    Am J Med; 2019 Mar; 132(3):e512-e513. PubMed ID: 30503878
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
    Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
    J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic liver disease].
    Privezentseva TV
    Vestn Rentgenol Radiol; 1985; (4):78-80. PubMed ID: 3000065
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literature.
    Moscetti L; Saltarelli R; Giuliani R; Fornarini G; Bezzi M; Cortesi E
    Tumori; 2000; 86(6):475-9. PubMed ID: 11218190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin receptor scintigraphy and endoscopic ultrasound for the diagnosis of insulinoma and gastrinoma].
    Zimmer T; Stölzel U; Liehr RM; Bäder M; Fett U; Hamm B; Wiedenmann B; Riecken EO
    Dtsch Med Wochenschr; 1995 Jan; 120(4):87-93. PubMed ID: 7835241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic pancreatic insulinoma with treatment-limiting thrombocytopenia.
    Nguyen AH; Donahue TR
    Am Surg; 2013 Mar; 79(3):E124-6. PubMed ID: 23461938
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.
    Winkelbauer FW; Nierderle B; Graf O; Prokesch R; Thurnher S; Wildling R; Lammer J
    Cardiovasc Intervent Radiol; 1995; 18(6):353-9. PubMed ID: 8591620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor induced local fibrogenic effect by hepatic metastasis of insulinoma.
    Longerich T; Ketterer K; Helmke BM; Friess H; Schirmacher P
    Virchows Arch; 2005 Jun; 446(6):680-1. PubMed ID: 15902484
    [No Abstract]   [Full Text] [Related]  

  • 16. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant insulinoma in childhood.
    Karachaliou F; Vlachopapadopoulou E; Kaldrymidis P; Simatos G; Zacharea M; Spanidou-Karvouni E; Michalacos S; Voros D
    J Pediatr Endocrinol Metab; 2006 May; 19(5):757-60. PubMed ID: 16789643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
    Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
    Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy].
    Carnaille B
    Ann Chir; 2000 Jul; 125(6):595-6. PubMed ID: 10986776
    [No Abstract]   [Full Text] [Related]  

  • 20. Unexpected Steatotic Liver Lesions.
    De Vito C; Rubbia-Brandt L; Toso C
    Gastroenterology; 2016 Jul; 151(1):32-3. PubMed ID: 27240321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.